These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical experience with the automatic implantable defibrillator. Mirowski M; Reid PR; Mower MM; Watkins L; Platia EV; Griffith LS; Veltri EP; Guarnieri T; Juanteguy JM Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():39-42. PubMed ID: 3938257 [TBL] [Abstract][Full Text] [Related]
3. The automatic implantable cardioverter-defibrillator: an overview. Mirowski M J Am Coll Cardiol; 1985 Aug; 6(2):461-6. PubMed ID: 3894475 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants. Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705 [TBL] [Abstract][Full Text] [Related]
6. Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system. Saksena S; Tullo NG; Krol RB; Mauro AM Arch Intern Med; 1989 Oct; 149(10):2333-9. PubMed ID: 2802898 [TBL] [Abstract][Full Text] [Related]
7. Clinical performance of the implantable cardioverter-defibrillator. Mirowski M; Reid PR; Mower MM; Watkins L; Platia EV; Griffith LS; Guarnieri T; Thomas A; Juanteguy JM Pacing Clin Electrophysiol; 1984 Nov; 7(6 Pt 2):1345-50. PubMed ID: 6209681 [TBL] [Abstract][Full Text] [Related]
8. Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias. Tchou PJ; Kadri N; Anderson J; Caceres JA; Jazayeri M; Akhtar M Ann Intern Med; 1988 Oct; 109(7):529-34. PubMed ID: 3262325 [TBL] [Abstract][Full Text] [Related]
9. Use of the automatic implantable cardioverter-defibrillator in the treatment of malignant ventricular tachyarrhythmias. Mirowski M; Reid PR; Mower MM; Watkins L; Platia EV; Griffith LS; Juanteguy JM Herz; 1984 Apr; 9(2):83-9. PubMed ID: 6714918 [TBL] [Abstract][Full Text] [Related]
10. The automatic implantable defibrillator. New Modality for treatment of life-threatening ventricular arrhythmias. Mirowski M; Mower MM; Reid PR; Watkins L; Langer A Pacing Clin Electrophysiol; 1982 May; 5(3):384-401. PubMed ID: 6179057 [TBL] [Abstract][Full Text] [Related]
12. Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias. The Guardian Multicenter Investigators Group. Saksena S; Poczobutt-Johanos M; Castle LW; Fogoros RN; Alpert BL; Kron J; Pacifico A; Griffin J; Ruskin JN; Kehoe RF J Am Coll Cardiol; 1992 Mar; 19(3):490-9. PubMed ID: 1537999 [TBL] [Abstract][Full Text] [Related]
13. Long-term outcome with the automatic implantable cardioverter-defibrillator. Winkle RA; Mead RH; Ruder MA; Gaudiani VA; Smith NA; Buch WS; Schmidt P; Shipman T J Am Coll Cardiol; 1989 May; 13(6):1353-61. PubMed ID: 2703616 [TBL] [Abstract][Full Text] [Related]
14. Surgical decisions in the management of sudden cardiac death and malignant ventricular arrhythmias. Subendocardial resection, the automatic internal defibrillator, or both. Hargrove WC; Josephson ME; Marchlinski FE; Miller JM J Thorac Cardiovasc Surg; 1989 Jun; 97(6):923-8. PubMed ID: 2724998 [TBL] [Abstract][Full Text] [Related]